Showing results (1111-1120 of 6,713) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|March 19, 2020
Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based ChemotherapyRong Ma, Qing Yang, Shengya Cao, et al.
Oncotargets and Therapy|March 19, 2020
Omega-3PUFA Attenuates MNU-Induced Colorectal Cancer in Rats by Blocking PI3K/AKT/Bcl-2 SignalingZhe Huang, Chun-An Liu, Peng-Zhu Cai, et al.
Oncotargets and Therapy|June 30, 2016
GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2Fang Huang, Jianguo Yin, Keyu Li, et al.
Oncotargets and Therapy|June 30, 2016
Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysisHai Wang, Libo Man, Guizhong Li, et al.
Oncotargets and Therapy|June 18, 2016
Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancerYvonne Le Ang, Joline Sj Lim, Ross A Soo
Oncotargets and Therapy|June 18, 2016
The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomyXu Feng, Kelei Zhu, Jinghua Liu, et al.
Oncotargets and Therapy|June 18, 2016
Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinomaYu Zhang, Shao-Liang Zhu, Jie Chen, et al.
Oncotargets and Therapy|May 5, 2016
The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cellsXiao-Juan Fu, Han-Xue Li, Kai Yang, et al.
Oncotargets and Therapy|May 5, 2016
Carvacrol suppresses proliferation and invasion in human oral squamous cell carcinomaWei Dai, Changfu Sun, Shaohui Huang, et al.
Oncotargets and Therapy|May 5, 2016
MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transitionShi-Bin Jiang, Xu-Jun He, Ying-Jie Xia, et al.
Pageof 672